Abhishek Vaish1, Saif Ahmed1, Anan Shetty1. 1. Institute of Medical Sciences, Medway Campus, Canterbury Christ Church University, Chatham, Kent, UK.
Abstract
BACKGROUND: Patient compliance to physiotherapy after surgical intervention is key to optimal functional outcome. This has been recognised by published literature over a number of decades. Improving and monitoring patient compliance remains a challenge. This paper explores the use of a website linked iPhone application that may be used to address this issue. PURPOSE: The purpose of this case study was to assess if the D+R Therapy application was of benefit to a patient and to assess the advantages and disadvantages of such a system. METHOD: One patient who underwent knee cartilage resurfacing surgery was followed up in the post-operative period. RESULTS/ CONCLUSION: The D+R Therapy platform may provide a timely and cost effective method of managing patients undergoing musculoskeletal physiotherapy. Costs may be reduced by exploiting the hardware patients already own, and identifying non-compliant patients who may be of interest to both healthcare providers and insurers. LEVEL OF EVIDENCE: Level IV.
BACKGROUND:Patient compliance to physiotherapy after surgical intervention is key to optimal functional outcome. This has been recognised by published literature over a number of decades. Improving and monitoring patient compliance remains a challenge. This paper explores the use of a website linked iPhone application that may be used to address this issue. PURPOSE: The purpose of this case study was to assess if the D+R Therapy application was of benefit to a patient and to assess the advantages and disadvantages of such a system. METHOD: One patient who underwent knee cartilage resurfacing surgery was followed up in the post-operative period. RESULTS/ CONCLUSION: The D+R Therapy platform may provide a timely and cost effective method of managing patients undergoing musculoskeletal physiotherapy. Costs may be reduced by exploiting the hardware patients already own, and identifying non-compliant patients who may be of interest to both healthcare providers and insurers. LEVEL OF EVIDENCE: Level IV.